ID1 and Familial prostate cancer: However, the medium derived from PC3-shId-1 is still incapable of inducing osteoblast mineralisation, suggesting that Id-1 might be sufficient to inhibit prostate cancer cell-mediated osteoblast mineralisation, but is not the sole regulator of this event.